Erianin mitigates diabetic cardiomyopathy via adenosine monophosphate-activated protein kinase-nuclear factor erythroid 2-related factor 2-heme oxygenase-1 pathway activation

Figure 6 Comparison of proinflammatory factor expression in type 2 diabetes mellitus mice. A: Level of tumor necrosis factor-α (TNF-α) in serum; B: Level of interleukin (IL)-1β in serum; C: Level of IL-6 in serum; D: mRNA level of TNF-α in heart tissues; E: mRNA level of IL-1β in heart tissues; F: mRNA level of IL-6 in heart tissues. Bar charts represent the mean ± SEM, n = 8. ^bP < 0.01 vs control group; ^cP < 0.001 vs control group; ^dP < 0.05 vs model group; ^eP < 0.01 vs model group; ^fP < 0.001 vs model group; TNF-α: Tumor necrosis factor-α; IL: Interleukin.